MAHATME SANDESH (CFO) reported 1 transaction at VOR BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0001511034-25-000006
+694.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.39M acquired · 694.14K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−694.14K
Price / share
—
Trade value
—
% of position
New position
12/5/2025
694.14K→0.00
Total
Net shares
−694.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | D · Disposition | −694.14K | — | — | New position | 694.14K | 0.00 |
| Total | −694.14K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
1.39M shares
Shares
+1.39M
Strike price
17.80
Held after
1.39M
Exercisable
—
12/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock1.39M shares | 12/5/2025 | A · Award | +1.39M | 17.80 | — | 1.39M |